Author

F. D. Batista

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Approach:deep learning· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Research Focus:protein folding & dynamics· 1 Assay:protein structure· 1 Assay:proteomics· 1

Frequent Co-Authors

S. Kratochvil· 2 shared A. Barbieri· 1 shared A. C. Williams· 1 shared A. H. Idris· 1 shared A. Schon· 1 shared A. Y. Ye· 1 shared B. F. Haynes· 1 shared B. G. Bonilla· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

S. Kratochvil

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Humanized V(D)J-rearranging and TdT-expressing Mouse Vaccine Models with Physiological HIV-1 Broadly Neutralizing Antibody Precursors

S. Luo, C. Jing, A. Y. Ye, S. Kratochvil, C. A. Cottrell, J.-H. Koo, A. C. Williams, L. V. Francisco, H. Batra, E. Lamperti, O. Kalyuzhniy, Y. Zhang, A. Barbieri, J. P. Manis, B. F. Haynes, , F. W. Alt

This paper introduces new mouse models expressing human HIV-1 broadly neutralizing antibody (bnAb) precursors with more physiological levels and diversity, enhancing vaccine research for bnAb elicitation.

Proceedings of the National Academy of Sciences · Dec 27, 2022Peer-reviewedImmunology

In Silico Improvement of Highly Protective Anti-Malarial Antibodies

M. Mateo, P. Tripathi, L. Da Silva Pereira, P. Kiyuka, T. Liu, B. Zhang, Y. Yang, B. G. Bonilla, M. Dillon, M. Lee, C.-H. Shen, A. Schon, S. Kratochvil, F. D. Batista, A. H. Idris, , R. Rawi

The paper improves an anti-malarial antibody using an in silico pipeline, resulting in a variant with higher binding affinity and better malaria protection.

bioRxiv · Apr 8, 2022 · PreprintImmunology